Author: Bill Snyder
Nov. 20, 2017—Fifteen Vanderbilt faculty members conducting a range of biomedical and clinical research have been elected fellows of the American Association for the Advancement of Science. Six of the 15 have received funding through the university’s Trans-Institutional Programs initiative, which facilitates research and teaching collaborations across disciplines and are a core pillar of the university’s Academic Strategic Plan.
Nov. 16, 2017—Using sophisticated genome mining and gene manipulation techniques, researchers at Vanderbilt University Medical Center (VUMC) have solved a mystery that could lead to a new treatment approach for autism spectrum disorder (ASD).
Nov. 16, 2017—Kathryn Edwards, MD, professor of Pediatrics and the Sarah H. Sell and Cornelius Vanderbilt Professor at Vanderbilt University School of Medicine, is the recipient of the 2018 Maxwell Finland Award for Scientific Achievement from the National Foundation for Infectious Diseases (NFID).
Nov. 16, 2017—This summer the Vanderbilt Mouse Metabolic Phenotyping Center (MMPC) began its 17th year of continuous operation and federal support with a $5.5 million, five-year renewal grant from the National Institutes of Health (NIH).
Nov. 2, 2017—Basic research underway at Vanderbilt University Medical Center is raising hopes that one day it will be possible to reverse memory loss in people with Alzheimer’s disease and stop a major driver of cancer in its tracks.
Oct. 26, 2017—Researchers at Vanderbilt University Medical Center are leading an international effort to develop a universal influenza vaccine that would protect everyone against all strains of the flu anywhere in the world.
Oct. 19, 2017—Fatal drug overdoses in Davidson County more than doubled in the past four years and now exceed the death rates for homicides and motor vehicle accidents, yet few people with addiction can obtain the treatment they need, Nashville Mayor Megan Barry said Tuesday.
Oct. 19, 2017—Clinical and translational research at Vanderbilt University Medical Center (VUMC) is thriving.
Oct. 19, 2017—How epigenetic regulation of gene transcription forms new memories and triggers cancerous growth is the subject of the next Vanderbilt Discovery Lecture on Oct. 26.
Oct. 12, 2017—P. Jeffrey Conn, Ph.D., founding director of the Vanderbilt Center for Neuroscience Drug Discovery, has won a 2017 Research & Hope Award from the Pharmaceutical Research and Manufacturers of America (PhRMA) for outstanding research in the area of mental health.
Oct. 12, 2017—Researchers in the Vanderbilt Institute for Global Health (VIGH) have received two new grants from the National Institutes of Health (NIH) aimed at reducing the risk of kidney disease in HIV-infected adults and improving the treatment of epilepsy in children in Nigeria.